BRIEF published on 10/21/2024 at 16:39, 1 year 10 months ago Cherry SE Achieves Key Milestone with SmartLink Approval Cherry SE Healthcare Innovation SmartLink Approval EHealth Digitalization Gematik Certification
PRESS RELEASE published on 10/21/2024 at 16:34, 1 year 10 months ago Cherry SE receives product approval for SmartLink from gematik, advancing the digitalization of the German healthcare sector Cherry SE's subsidiary, CHERRY Digital Health, achieves product approval for SmartLink from gematik, enhancing digitalization in German healthcare sector Cherry SE Gematik SmartLink CHERRY Digital Health EHealth Solutions
BRIEF published on 10/02/2024 at 16:40, 1 year 11 months ago Cherry SE Misses Revenue Forecast for Q3 2024 due to Weak German Market Revenue Forecast Cherry SE German Market Q3 2024 Cost Reductions
BRIEF published on 10/02/2024 at 16:35, 1 year 11 months ago Restructuring of Cherry SE's Gaming & Office Peripherals Division Cherry SE Restructuring European Markets CEO Oliver Kaltner Gaming & Office Peripherals
PRESS RELEASE published on 10/02/2024 at 16:35, 1 year 11 months ago Cherry SE misses revenue forecast for the third quarter of 2024 due to weak German market Cherry SE misses Q3 revenue forecast due to weak German market conditions, anticipates EUR 22 million revenue. Cost cuts and review of 2024 forecast ongoing Revenue Forecast Cherry SE Germany Q3 Cost Cuts
PRESS RELEASE published on 10/02/2024 at 16:30, 1 year 11 months ago Restructuring of the Gaming & Office Peripherals division Cherry SE announces restructuring of Gaming & Office Peripherals division. CEO takes over interim management, realignment of sales organization Cherry SE Restructuring CEO Sales Organization Gaming & Office Peripherals
BRIEF published on 10/02/2024 at 16:28, 1 year 11 months ago Cherry SE Misses Q3 2024 Sales Forecast Adjusted EBITDA Cherry SE Revenue Miss Q3 2024 Sales Forecast
PRESS RELEASE published on 10/02/2024 at 16:23, 1 year 11 months ago EQS-Adhoc: Cherry SE: Forecast miss Q3/2024 Cherry SE misses Q3/2024 sales forecast leading to a profit warning due to lower consolidated revenue, impacting EBITDA margin. Management Board assessing impact EBITDA Margin Cherry SE Management Board Sales Forecast Profit Warning
BRIEF published on 09/17/2024 at 16:35, 2 years ago Cherry SE: SmartLink Product Approval is Imminent Cherry SE Saas SmartLink Product Approval Healthcare Digitalization
PRESS RELEASE published on 09/17/2024 at 16:30, 2 years ago Cherry SE: SmartLink product approval is imminent Cherry SE anticipates imminent approval for its CHERRY SmartLink product, a new eHealth card terminal software solution, aiming to revolutionize healthcare digitalization Healthcare Cherry SE Digitalization SmartLink Product Approval
Published on 09/17/2026 at 15:55, 5 hours 16 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 5 hours 46 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 6 hours 11 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 6 hours 11 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 6 hours 21 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 2 hours 11 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 2 hours 12 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 2 hours 46 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 3 hours 1 minute ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 3 hours 25 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 3 hours 31 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 3 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 14 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
